Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

114.50p
   
  • Change Today:
      4.50p
  • 52 Week High: 117.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 642,062
  • Market Cap: £96.96m
  • RiskGrade: 196

Deal with Barclays    Trade now with Barclays Stockbrokers

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim 9.92 (1.96) (1.76)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 10.37 0.88 1.86p n/a n/a n/a n/a 0.0%
31-Dec-19 13.44 0.50 2.46p 41.5 1.3 +32% n/a 0.0%
31-Dec-20 12.70 (0.68) 0.74p 180.4 n/a -70% n/a 0.0%
31-Dec-21 13.94 0.46 0.67p 152.2 n/a -10% n/a 0.0%
31-Dec-22 19.50 0.56 0.86p 87.8 3.1 +28% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 87.79 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Diaceutics Market Data

Currency UK Pounds
Share Price 114.50p
Change Today 4.50p
% Change 4.09 %
52 Week High 117.00
52 Week Low 80.50
Volume 642,062
Shares Issued 84.68m
Market Cap £96.96m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.14% below the market average91.14% below the market average91.14% below the market average91.14% below the market average91.14% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Price Trend
76.84% above the market average76.84% above the market average76.84% above the market average76.84% above the market average76.84% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average
Income Not Available
Growth
9.86% above the market average9.86% above the market average9.86% above the market average9.86% above the market average9.86% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Diaceutics Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
11:53 110,000 @ 112.50p
11:53 110,000 @ 112.50p
17:07 50,000 @ 114.50p
17:03 110,000 @ 112.61p
16:43 112,000 @ 112.62p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page